Oral Etoposide in Relapsed or Refractory Ewing Sarcoma: A Monoinstitutional Experience in Children and Adolescents

2016 ◽  
Vol 102 (1) ◽  
pp. 84-88 ◽  
Author(s):  
Marta G. Podda ◽  
Roberto Luksch ◽  
Nadia Puma ◽  
Lorenza Gandola ◽  
Carlo Morosi ◽  
...  
2011 ◽  
Vol 57 (1) ◽  
pp. 69-75 ◽  
Author(s):  
Jaume Mora ◽  
Carmen de Torres ◽  
Andreu Parareda ◽  
Ferran Torner ◽  
Patricia Galván ◽  
...  

2013 ◽  
Vol 29 (12) ◽  
pp. 1303-1309 ◽  
Author(s):  
Sajid S. Qureshi ◽  
Siddharth Laskar ◽  
Seema Kembhavi ◽  
Sanjay Talole ◽  
Girish Chinnaswamy ◽  
...  

2018 ◽  
Vol 11 (3) ◽  
pp. 729-734 ◽  
Author(s):  
Montreh Tavakkoli ◽  
Lisa Mueller

Ewing sarcoma is an aggressive mesenchymal malignancy. It is the second most common bone tumor among children and adolescents and less commonly presents as a soft tissue or primary skin lesion. Cutaneous Ewing sarcoma has only been reported in case reports and case series. In this article, we describe a 12-year-old Hispanic female cured of localized, cutaneous Ewing sarcoma (pT1aN0M0) at the 40-month follow-up following surgical resection and adjuvant chemotherapy according to the COG AEWS1031 protocol for Ewing sarcoma of the bone. To our knowledge, this is the first article to provide a potential biological explanation for the differences in the prognosis of Ewing sarcoma of the bone, soft tissue, and skin.


2003 ◽  
Vol 40 (3) ◽  
pp. 141-147 ◽  
Author(s):  
A.G. Shankar ◽  
S. Ashley ◽  
A.W. Craft ◽  
C.R. Pinkerton

2021 ◽  
Author(s):  
Virginia Livellara ◽  
Luca Bergamaschi ◽  
Nadia Puma ◽  
Stefano Chiaravalli ◽  
Marta Podda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document